BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5049924)

  • 21. Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.
    Vogel CL; Comis R; Ziegler JL; Kiryabwire JW
    Cancer Chemother Rep; 1971 Apr; 55(2):143-9. PubMed ID: 5118684
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
    Hill GJ; Larsen RR
    Oncology; 1972; 26(2):206-22. PubMed ID: 4626137
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
    Gerner RE; Moore GE; Didolkar MS
    Cancer; 1973 Oct; 32(4):756-60. PubMed ID: 4751912
    [No Abstract]   [Full Text] [Related]  

  • 24. Azelaic acid: potential as a general antitumoural agent.
    Breathnach AS
    Med Hypotheses; 1999 Mar; 52(3):221-6. PubMed ID: 10362281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of the action of antitumor compounds on primary explants from human tumors].
    Navashin SM; Fomina IP; Osokina LI; Zharikov AA
    Antibiotiki; 1967 Sep; 12(9):803-7. PubMed ID: 4171894
    [No Abstract]   [Full Text] [Related]  

  • 26. How to use cancer chemotherapy.
    Dollinger MR
    Am Fam Physician; 1971 Jun; 3(6):73-84. PubMed ID: 4325596
    [No Abstract]   [Full Text] [Related]  

  • 27. FIVB--a new combination of drugs in the treatment of cancer.
    Van Eden EB; Falkson G; Van der Merwe AM; Van Dyk JJ; Falkson HC
    S Afr Med J; 1973 Jun; 47(23):982-4. PubMed ID: 4714282
    [No Abstract]   [Full Text] [Related]  

  • 28. [Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
    Horton J; Olson K
    Poumon Coeur; 1968; 24(1):59-62. PubMed ID: 4968016
    [No Abstract]   [Full Text] [Related]  

  • 29. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
    Nathanson L; Wolter J; Horton J; Colsky J; Shnider BI; Schilling A
    Clin Pharmacol Ther; 1971; 12(6):955-62. PubMed ID: 5134998
    [No Abstract]   [Full Text] [Related]  

  • 30. Postoperative chemotherapy for prognostically poor mammary, bowel and renal carcinoma.
    Bateman JC
    South Med J; 1970 Jun; 63(6):715-20. PubMed ID: 5446235
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prophylaxis of asphyxia neonatorum by administration of ethymizol to parturients].
    Strukov VA
    Akush Ginekol (Mosk); 1973 Nov; 49(11):61-3. PubMed ID: 4789582
    [No Abstract]   [Full Text] [Related]  

  • 32. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
    Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA
    Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911
    [No Abstract]   [Full Text] [Related]  

  • 33. Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma.
    Moertel CG
    Br J Cancer; 1976 Sep; 34(3):325-34. PubMed ID: 184809
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms.
    Lissoni P; Barni S; Tancini G; Viviani S; Rovelli F; Rescaldani R; Fiorelli G
    J Biol Regul Homeost Agents; 1989; 3(3):131-3. PubMed ID: 2560317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical valuation of the subrenal capsule (SRC) assay and its use in experimental therapy.
    Arnold W; Nowak C; Naundorf H; Kunde D; Wildner GP
    Strahlenther Onkol; 1989 Jul; 165(7):532-3. PubMed ID: 2546269
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
    Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
    [No Abstract]   [Full Text] [Related]  

  • 37. [Transition of criteria for the determination of efficacy of cancer chemotherapy].
    Koyama Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):153-63. PubMed ID: 3942397
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.
    Braich TA; Salmon SE; Robertone A; Alberts DS; Jones SE; Miller TP; Garewal HS
    Invest New Drugs; 1986; 4(3):269-74. PubMed ID: 3818231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience with weekly intravenous 5-fluorouracil in advanced colonic and rectal neoplasms].
    Marcuello Gaspar E; Germa Lluch JR; Abad Esteve A; Badia Canto A
    Rev Esp Enferm Apar Dig; 1979 Apr; 55(4):365-76. PubMed ID: 493637
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.